{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:14:51Z","timestamp":1784049291970,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-026-02214-z","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:03:59Z","timestamp":1777482239000},"page":"1121-1133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oncological efficacy, functional outcomes and safety of MR-guided ultrasound ablation (MRgFUS\/TULSA) for localized prostate cancer: a scoping review"],"prefix":"10.1007","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2465-1185","authenticated-orcid":false,"given":"Giuseppe","family":"Salvaggio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Midiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Gagliardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Benfante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Comelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lo Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Galia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Midiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"2214_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"2214_CR2","volume-title":"TNM Classification of Malignant Tumours","author":"J Brierley","year":"2017","unstructured":"Brierley J, Gospodarowicz MK, Wittekind C (2017) TNM Classification of Malignant Tumours, 8th edn. John Wiley & Sons, Incorporated, Chicester","edition":"8"},{"key":"2214_CR3","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","volume":"375","author":"JL Donovan","year":"2016","unstructured":"Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, Blazeby JM, Peters TJ, Holding P, Bonnington S, Lennon T, Bradshaw L, Cooper D, Herbert P, Howson J, Jones A, Lyons N, Salter E, Thompson P, Tidball S, Blaikie J, Gray C, Bollina P, Catto J, Doble A, Doherty A, Gillatt D, Kockelbergh R, Kynaston H, Paul A, Powell P, Prescott S, Rosario DJ, Rowe E, Davis M, Turner EL, Martin RM, Neal DE (2016) Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 375:1425\u20131437. https:\/\/doi.org\/10.1056\/NEJMoa1606221","journal-title":"N Engl J Med"},{"key":"2214_CR4","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jama.2017.1652","volume":"317","author":"RC Chen","year":"2017","unstructured":"Chen RC, Basak R, Meyer A-M, Kuo T-M, Carpenter WR, Agans RP, Broughman JR, Reeve BB, Nielsen ME, Usinger DS, Spearman KC, Walden S, Kaleel D, Anderson M, St\u00fcrmer T, Godley PA (2017) Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA 317:1141. https:\/\/doi.org\/10.1001\/jama.2017.1652","journal-title":"JAMA"},{"key":"2214_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, Van Den Bergh RCN, Briers E, Van Den Broeck T, Cumberbatch MG, De Santis M, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Grummet J, Henry AM, Van Der Kwast TH, Lam TB, Lardas M, Liew M, Mason MD, Moris L, Oprea-Lager DE, Van Der Poel HG, Rouvi\u00e8re O, Schoots IG, Tilki D, Wiegel T, Willemse P-PM, Cornford P (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 79:243\u2013262. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.042","journal-title":"Eur Urol"},{"key":"2214_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/CCO.0000000000000515","volume":"31","author":"M Ahdoot","year":"2019","unstructured":"Ahdoot M, Lebastchi AH, Turkbey B, Wood B, Pinto PA (2019) Contemporary treatments in prostate cancer focal therapy. Curr Opin Oncol 31:200\u2013206. https:\/\/doi.org\/10.1097\/CCO.0000000000000515","journal-title":"Curr Opin Oncol"},{"key":"2214_CR7","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham AP, Oldroyd R, Parker C, Emberton M (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815\u2013822. https:\/\/doi.org\/10.1016\/S0140-6736(16)32401-1","journal-title":"Lancet"},{"key":"2214_CR8","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.juro.2007.08.072","volume":"178","author":"SE Eggener","year":"2007","unstructured":"Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L, International Task Force on Prostate Cancer and the Focal Lesion Paradigm\u2020 (2007) Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 178:2260\u20132267. https:\/\/doi.org\/10.1016\/j.juro.2007.08.072","journal-title":"J Urol"},{"key":"2214_CR9","doi-asserted-by":"publisher","first-page":"W177","DOI":"10.2214\/AJR.14.13098","volume":"205","author":"S Ghai","year":"2015","unstructured":"Ghai S, Louis AS, Van Vliet M, Lindner U, Haider MA, Hlasny E, Spensieri P, Van Der Kwast TH, McCluskey SA, Kucharczyk W, Trachtenberg J (2015) Real-time MRI-guided focused ultrasound for focal therapy of locally confined low-risk prostate cancer: feasibility and preliminary outcomes. Am J Roentgenol 205:W177\u2013W184. https:\/\/doi.org\/10.2214\/AJR.14.13098","journal-title":"Am J Roentgenol"},{"key":"2214_CR10","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1007\/s00330-018-5409-z","volume":"28","author":"S Ghai","year":"2018","unstructured":"Ghai S, Perlis N, Lindner U, Hlasny E, Haider MA, Finelli A, Zlotta AR, Kulkarni GS, van der Kwast TH, McCluskey SA, Kucharczyk W, Trachtenberg J (2018) Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial. Eur Radiol 28:4281\u20134287. https:\/\/doi.org\/10.1007\/s00330-018-5409-z","journal-title":"Eur Radiol"},{"key":"2214_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1069518","volume":"12","author":"M Alabousi","year":"2022","unstructured":"Alabousi M, Ghai S (2022) Magnetic resonance imaging-guided ultrasound ablation for prostate cancer\u2014a contemporary review of performance. Front Oncol 12:1069518. https:\/\/doi.org\/10.3389\/fonc.2022.1069518","journal-title":"Front Oncol"},{"key":"2214_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3109\/02656736.2010.503670","volume":"26","author":"R Chopra","year":"2010","unstructured":"Chopra R, Burtnyk M, N\u2019djin WA, Bronskill M (2010) MRI-controlled transurethral ultrasound therapy for localised prostate cancer. Int J Hyperthermia 26:804\u2013821. https:\/\/doi.org\/10.3109\/02656736.2010.503670","journal-title":"Int J Hyperthermia"},{"key":"2214_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2015.12.029","volume":"70","author":"JL Chin","year":"2016","unstructured":"Chin JL, Billia M, Relle J, Roethke MC, Popeneciu IV, Kuru TH, Hatiboglu G, Mueller-Wolf MB, Motsch J, Romagnoli C, Kassam Z, Harle CC, Hafron J, Nandalur KR, Chronik BA, Burtnyk M, Schlemmer H-P, Pahernik S (2016) Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: a prospective phase 1 clinical trial. Eur Urol 70:447\u2013455. https:\/\/doi.org\/10.1016\/j.eururo.2015.12.029","journal-title":"Eur Urol"},{"key":"2214_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/JU.0000000000001362","volume":"205","author":"L Klotz","year":"2021","unstructured":"Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, Raman S, Oto A, F\u00fctterer J, Serrallach M, Relle J, Lotan Y, Heidenreich A, Bonekamp D, Haider M, Tirkes T, Arora S, Macura KJ, Costa DN, Persigehl T, Pantuck AJ, Bomers J, Burtnyk M, Staruch R, Eggener S (2021) Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate cancer. J Urol 205:769\u2013779. https:\/\/doi.org\/10.1097\/JU.0000000000001362","journal-title":"J Urol"},{"key":"2214_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/21681805.2020.1814857","volume":"54","author":"M Anttinen","year":"2020","unstructured":"Anttinen M, M\u00e4kel\u00e4 P, Nurminen P, Yli-Pietil\u00e4 E, Suomi V, Sainio T, Saunavaara J, Taimen P, Blanco Sequeiros R, Bostr\u00f6m PJ (2020) Palliative MRI-guided transurethral ultrasound ablation for symptomatic locally advanced prostate cancer. Scand J Urol 54:481\u2013486. https:\/\/doi.org\/10.1080\/21681805.2020.1814857","journal-title":"Scand J Urol"},{"key":"2214_CR16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.231473","volume":"310","author":"S Ghai","year":"2024","unstructured":"Ghai S, Finelli A, Corr K, Lajkosz K, McCluskey S, Chan R, Gertner M, Van Der Kwast TH, Incze PF, Zlotta AR, Kucharczyk W, Perlis N (2024) MRI-guided focused ultrasound focal therapy for intermediate-risk prostate cancer: final results from a 2-year phase II clinical trial. Radiology 310:e231473. https:\/\/doi.org\/10.1148\/radiol.231473","journal-title":"Radiology"},{"key":"2214_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.euo.2020.12.008","volume":"4","author":"AS Bates","year":"2021","unstructured":"Bates AS, Ayers J, Kostakopoulos N, Lumsden T, Schoots IG, Willemse P-PM, Yuan Y, Van Den Bergh RCN, Grummet JP, Van Der Poel HG, Rouvi\u00e8re O, Moris L, Cumberbatch MG, Lardas M, Liew M, Van Den Broeck T, Gandaglia G, Fossati N, Briers E, De Santis M, Fanti S, Gillessen S, Oprea-Lager DE, Ploussard G, Henry AM, Tilki D, Van Der Kwast TH, Wiegel T, N\u2019Dow J, Mason MD, Cornford P, Mottet N, Lam TBL (2021) A systematic review of focal ablative therapy for clinically localised prostate cancer in comparison with standard management options: limitations of the available evidence and recommendations for clinical practice and further research. Eur Urol Oncol 4:405\u2013423. https:\/\/doi.org\/10.1016\/j.euo.2020.12.008","journal-title":"Eur Urol Oncol"},{"key":"2214_CR18","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/S1470-2045(22)00251-0","volume":"23","author":"B Ehdaie","year":"2022","unstructured":"Ehdaie B, Tempany CM, Holland F, Sjoberg DD, Kibel AS, Trinh Q-D, Durack JC, Akin O, Vickers AJ, Scardino PT, Sperling D, Wong JYC, Yuh B, Woodrum DA, Mynderse LA, Raman SS, Pantuck AJ, Schiffman MH, McClure TD, Sonn GA, Ghanouni P (2022) MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study. Lancet Oncol 23:910\u2013918. https:\/\/doi.org\/10.1016\/S1470-2045(22)00251-0","journal-title":"Lancet Oncol"},{"key":"2214_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2023.100506","volume":"11","author":"P M\u00e4kel\u00e4","year":"2023","unstructured":"M\u00e4kel\u00e4 P, Anttinen M, Wright C, Sainio T, Bostr\u00f6m PJ, Sequeiros RB (2023) Evolution of non-perfused volume after transurethral ultrasound ablation of prostate: a retrospective 12-month analysis. Eur J Radiol Open 11:100506. https:\/\/doi.org\/10.1016\/j.ejro.2023.100506","journal-title":"Eur J Radiol Open"},{"key":"2214_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.euros.2024.11.001","volume":"71","author":"M Anttinen","year":"2025","unstructured":"Anttinen M, M\u00e4kel\u00e4 P, Nurminen P, P\u00e4rssinen H, Malaspina S, Sainio T, H\u00f6german M, Taimen P, Blanco Sequeiros R, Bostr\u00f6m PJ (2025) Salvage magnetic resonance imaging-guided transurethral ultrasound ablation for localized radiorecurrent prostate cancer. Eur Urol Open Sci 71:69\u201377. https:\/\/doi.org\/10.1016\/j.euros.2024.11.001","journal-title":"Eur Urol Open Sci"},{"key":"2214_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tun\u00e7alp \u00d6, Straus SE (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467\u2013473. https:\/\/doi.org\/10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"key":"2214_CR22","unstructured":"(2023) Corporation for Digital Scholarship"},{"key":"2214_CR23","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J (2003) Methodological index for non-randomized studies ( MINORS ): development and validation of a new instrument. ANZ J Surg 73:712\u2013716. https:\/\/doi.org\/10.1046\/j.1445-2197.2003.02748.x","journal-title":"ANZ J Surg"},{"key":"2214_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1148\/radiol.2021202717","volume":"298","author":"S Ghai","year":"2021","unstructured":"Ghai S, Finelli A, Corr K, Chan R, Jokhu S, Li X, McCluskey S, Konukhova A, Hlasny E, van der Kwast TH, Incze PF, Zlotta AR, Hamilton RJ, Haider MA, Kucharczyk W, Perlis N (2021) MRI-guided focused ultrasound ablation for localized intermediate-risk prostate cancer: early results of a Phase II trial. Radiology 298:695\u2013703. https:\/\/doi.org\/10.1148\/radiol.2021202717","journal-title":"Radiology"},{"key":"2214_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.782546","volume":"11","author":"G Hatiboglu","year":"2021","unstructured":"Hatiboglu G, Popeneciu V, Bonekamp D, Burtnyk M, Staruch R, Distler F, Radtke JP, Motsch J, Schlemmer HP, Pahernik S, Nyarangi-Dix J (2021) Single-center evaluation of treatment success using two different protocols for MRI-guided transurethral ultrasound ablation of localized prostate cancer. Front Oncol 11:782546. https:\/\/doi.org\/10.3389\/fonc.2021.782546","journal-title":"Front Oncol"},{"key":"2214_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jvir.2019.12.802","volume":"31","author":"KM Sundaram","year":"2020","unstructured":"Sundaram KM, Staruch R, Burtnyk M, Lane JS, Penson DF, Arora SS (2020) MR imaging-guided transurethral ultrasound ablation of localized prostate cancer: preliminary experience from a single center in a prospective, multi-center, single-arm clinical trial. J Vasc Interv Radiol 31:740-746.e4. https:\/\/doi.org\/10.1016\/j.jvir.2019.12.802","journal-title":"J Vasc Interv Radiol"},{"key":"2214_CR27","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.240009","volume":"6","author":"RR Bitton","year":"2024","unstructured":"Bitton RR, Shao W, Chodakeiwitz Y, Brunsing RL, Sonn G, Rusu M, Ghanouni P (2024) Intraprocedural diffusion-weighted imaging for predicting ablation zone during MRI-guided focused ultrasound of prostate cancer. Radiol Imaging Cancer 6:e240009. https:\/\/doi.org\/10.1148\/rycan.240009","journal-title":"Radiol Imaging Cancer"},{"key":"2214_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1148\/radiol.2017161650","volume":"285","author":"KJ Tay","year":"2017","unstructured":"Tay KJ, Cheng CWS, Lau WKO, Khoo J, Thng CH, Kwek JW (2017) Focal therapy for prostate cancer with in-bore MR-guided focused ultrasound: two-year follow-up of a Phase I trial-complications and functional outcomes. Radiology 285:620\u2013628. https:\/\/doi.org\/10.1148\/radiol.2017161650","journal-title":"Radiology"},{"key":"2214_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/21681805.2019.1660707","volume":"53","author":"M Anttinen","year":"2019","unstructured":"Anttinen M, M\u00e4kel\u00e4 P, Suomi V, Kiviniemi A, Saunavaara J, Sainio T, Horte A, Eklund L, Taimen P, Sequeiros RB, Bostr\u00f6m PJ (2019) Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer. Scand J Urol 53:295\u2013302. https:\/\/doi.org\/10.1080\/21681805.2019.1660707","journal-title":"Scand J Urol"},{"key":"2214_CR30","doi-asserted-by":"publisher","first-page":"830.e9","DOI":"10.1016\/j.urolonc.2021.04.022","volume":"39","author":"A Lumiani","year":"2021","unstructured":"Lumiani A, Samun D, Sroka R, Muschter R (2021) Single center retrospective analysis of fifty-two prostate cancer patients with customized MR-guided transurethral ultrasound ablation (TULSA). Urol Oncol 39:830.e9-830.e16. https:\/\/doi.org\/10.1016\/j.urolonc.2021.04.022","journal-title":"Urol Oncol"},{"key":"2214_CR31","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.259015","volume":"7","author":"R Rajeev","year":"2025","unstructured":"Rajeev R (2025) Clinical outcomes of MRI-guided transurethral US ablation (MRI-TULSA) of localized prostate cancer. Radiol Imaging Cancer 7:e259015. https:\/\/doi.org\/10.1148\/rycan.259015","journal-title":"Radiol Imaging Cancer"},{"key":"2214_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-023-01306-6","volume":"23","author":"I Peters","year":"2023","unstructured":"Peters I, Hensen B, Glandorf J, Gutberlet M, Dohna M, Struckmann S, Kuczyk MA, Wacker F, Hellms S (2023) First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study. BMC Urol 23:142. https:\/\/doi.org\/10.1186\/s12894-023-01306-6","journal-title":"BMC Urol"},{"key":"2214_CR33","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1089\/end.2024.0301","volume":"39","author":"L Engelage","year":"2025","unstructured":"Engelage L, Muschter R (2025) Transurethral ultrasound ablation for treatment of localized prostate cancer and benign prostatic hyperplasia (BPH). J Endourol 39:S23\u2013S26. https:\/\/doi.org\/10.1089\/end.2024.0301","journal-title":"J Endourol"},{"key":"2214_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/21681805.2020.1752795","volume":"54","author":"SM Nair","year":"2020","unstructured":"Nair SM, Stern N, Dewar M, Siddiqui K, Smith E, Gomez JA, Moussa M, Chin JL (2020) Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy. Scand J Urol 54:215\u2013219. https:\/\/doi.org\/10.1080\/21681805.2020.1752795","journal-title":"Scand J Urol"},{"key":"2214_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/end.2020.0511","volume":"35","author":"D Elterman","year":"2021","unstructured":"Elterman D, Li W, Hatiboglu G, Relle J, Zorn KC, Bhojani N, Chin J (2021) Relief of lower urinary tract symptoms after MRI-guided transurethral ultrasound ablation for localized prostate cancer: subgroup analyses in patients with concurrent cancer and benign prostatic hyperplasia. J Endourol 35:497\u2013505. https:\/\/doi.org\/10.1089\/end.2020.0511","journal-title":"J Endourol"},{"key":"2214_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00345-019-02784-w","volume":"38","author":"G Hatiboglu","year":"2020","unstructured":"Hatiboglu G, Popeneciu V, Bonekamp D, Burtnyk M, Staruch R, Pahernik S, Tosev G, Radtke JP, Motsch J, Schlemmer HP, Hohenfellner M, Nyarangi-Dix J (2020) Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate tissue in patients with localized prostate cancer: single-center evaluation of 6-month treatment safety and functional outcomes of intensified treatment parameters. World J Urol 38:343\u2013350. https:\/\/doi.org\/10.1007\/s00345-019-02784-w","journal-title":"World J Urol"},{"key":"2214_CR37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1089\/end.2024.0700","volume":"39","author":"E Bochner","year":"2025","unstructured":"Bochner E, Schulte V, Lotan Y, Meng X, Costa DN (2025) Feasibility and short-term safety of hydrogel spacer before treatment with magnetic resonance imaging-guided transurethral ultrasound ablation for prostate cancer treatment. J Endourol 39:418\u2013425. https:\/\/doi.org\/10.1089\/end.2024.0700","journal-title":"J Endourol"},{"key":"2214_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/end.2022.0214","volume":"37","author":"MJ Rabinowitz","year":"2023","unstructured":"Rabinowitz MJ, Haney NM, Myers AA, Dora CD, Pavlovich CP (2023) Urinary outcomes after magnetic resonance imaging-guided whole-gland transurethral ultrasound ablation for prostate cancer: comparison of suprapubic tube to indwelling urethral catheter. J Endourol 37:1\u20137. https:\/\/doi.org\/10.1089\/end.2022.0214","journal-title":"J Endourol"},{"key":"2214_CR39","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1177\/0284185120976931","volume":"62","author":"P M\u00e4kel\u00e4","year":"2021","unstructured":"M\u00e4kel\u00e4 P, Anttinen M, Suomi V, Steiner A, Saunavaara J, Sainio T, Horte A, Taimen P, Bostr\u00f6m P, Blanco Sequeiros R (2021) Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer. Acta Radiol 62:1687\u20131695. https:\/\/doi.org\/10.1177\/0284185120976931","journal-title":"Acta Radiol"},{"key":"2214_CR40","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1177\/02841851221108292","volume":"64","author":"P M\u00e4kel\u00e4","year":"2023","unstructured":"M\u00e4kel\u00e4 P, Wright C, Anttinen M, Bostr\u00f6m PJ, Blanco Sequeiros R (2023) Safety and efficacy of MRI-guided transurethral ultrasound ablation for radiorecurrent prostate cancer in the presence of gold fiducial markers. Acta Radiol 64:1228\u20131237. https:\/\/doi.org\/10.1177\/02841851221108292","journal-title":"Acta Radiol"},{"key":"2214_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.euros.2020.10.007","volume":"22","author":"M Anttinen","year":"2020","unstructured":"Anttinen M, Makela P, Viitala A, Nurminen P, Suomi V, Sainio T, Saunavaara J, Taimen P, Sequeiros RB, Bostr\u00f6m PJ (2020) Salvage magnetic resonance imaging\u2013guided transurethral ultrasound ablation for localized radiorecurrent prostate cancer: 12-month functional and oncological results. Eu Uro Op Sci 22:79\u201387. https:\/\/doi.org\/10.1016\/j.euros.2020.10.007","journal-title":"Eu Uro Op Sci"},{"key":"2214_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.juro.2016.06.100","volume":"197","author":"E Ramsay","year":"2017","unstructured":"Ramsay E, Mougenot C, Staruch R, Boyes A, Kazem M, Bronskill M, Foster H, Sugar L, Haider M, Klotz L, Chopra R (2017) Evaluation of focal ablation of magnetic resonance imaging defined prostate cancer using magnetic resonance imaging controlled transurethral ultrasound therapy with prostatectomy as the reference standard. J Urol 197:255\u2013261. https:\/\/doi.org\/10.1016\/j.juro.2016.06.100","journal-title":"J Urol"},{"key":"2214_CR43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/bju.16746","volume":"136","author":"N Pyrgidis","year":"2025","unstructured":"Pyrgidis N, Chaloupka M, Ebner B, Volz Y, Weinhold P, Marcon J, Eismann L, Stief CG, Schulz GB, Apfelbeck M (2025) Perioperative complications of focal therapy for prostate cancer: results from the German Nationwide Inpatient Data (GRAND) study. BJU Int 136:306\u2013313. https:\/\/doi.org\/10.1111\/bju.16746","journal-title":"BJU Int"},{"key":"2214_CR44","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jvir.2025.05.024","volume":"36","author":"T Tricard","year":"2025","unstructured":"Tricard T, Cazzato RL, Schroeder A, De Mathelin M, Barhoumi C, Gaillard V, Sauleau E, Gangi A, Lang H (2025) Magnetic Resonance Imaging-guided Transurethral Ultrasound Ablation (TULSA) of localized prostate cancer: a prospective trial. J Vasc Interv Radiol 36:1401\u20131408. https:\/\/doi.org\/10.1016\/j.jvir.2025.05.024","journal-title":"J Vasc Interv Radiol"},{"key":"2214_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2025.100636","volume":"80","author":"CFA Matalani","year":"2025","unstructured":"Matalani CFA, Costa MSS, Rocha MRD, Lopes RI, Talizin TB, BessaJ\u00fanior J, Nahas WC, Ribeiro-Filho LA, Suartz CV (2025) Minimally invasive radical prostatectomy versus open radical prostatectomy: a systematic review and meta-analysis of randomized control trials. Clinics 80:100636. https:\/\/doi.org\/10.1016\/j.clinsp.2025.100636","journal-title":"Clinics"},{"key":"2214_CR46","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.eururo.2024.08.030","volume":"86","author":"N Van As","year":"2024","unstructured":"Van As N, Yasar B, Griffin C, Patel J, Tree AC, Ostler P, Van Der Voet H, Ford D, Tolan S, Wells P, Mahmood R, Winkler M, Chan A, Thompson A, Ogden C, Naismith O, Pugh J, Manning G, Brown S, Burnett S, Hall E (2024) Radical prostatectomy versus stereotactic radiotherapy for clinically localised prostate cancer: results of the PACE-A Randomised Trial. Eur Urol 86:566\u2013576. https:\/\/doi.org\/10.1016\/j.eururo.2024.08.030","journal-title":"Eur Urol"},{"key":"2214_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s40349-016-0054-y","volume":"4","author":"B Yuh","year":"2016","unstructured":"Yuh B, Liu A, Beatty R, Jung A, Wong JYC (2016) Focal therapy using magnetic resonance image-guided focused ultrasound in patients with localized prostate cancer. J Ther Ultrasound 4:8. https:\/\/doi.org\/10.1186\/s40349-016-0054-y","journal-title":"J Ther Ultrasound"},{"key":"2214_CR48","doi-asserted-by":"publisher","DOI":"10.1063\/1.4977616","volume":"1821","author":"A Napoli","year":"2017","unstructured":"Napoli A, Caliolo G, Boni F, Anzidei M, Catalano C (2017) Focal therapy for localized unifocal and multifocal prostate cancer: a prospective development study using real time MR guided focused ultrasound. AIP Conf Proc 1821:030004. https:\/\/doi.org\/10.1063\/1.4977616","journal-title":"AIP Conf Proc"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02214-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-026-02214-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02214-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:02:27Z","timestamp":1784048547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-026-02214-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["2214"],"URL":"https:\/\/doi.org\/10.1007\/s11547-026-02214-z","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}